• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性核上性麻痹中白质变化对临床表型的影响。

The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy.

作者信息

Tepedino Maria Francesca, Diana Francesco, Abate Filomena, Avallone Anna Rosa, Caterino Miriam, Erro Roberto, Pellecchia Maria Teresa, Manara Renzo, Barone Paolo, Picillo Marina

机构信息

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via Allende, 84131, Baronissi, Salerno, Italy.

Department of Neuroradiology, Azienda Ospedaliera Universitaria San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.

出版信息

J Neurol. 2024 Oct;271(10):6866-6875. doi: 10.1007/s00415-024-12662-0. Epub 2024 Sep 2.

DOI:10.1007/s00415-024-12662-0
PMID:39222284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11447107/
Abstract

White matter hyperintensities (WMH) are considered magnetic brain imaging (MRI) biomarkers of cerebral small vessel disease but their clinical role in neurodegenerative-related disorders is poorly understood. This study describes the distribution of WMH on brain MRI in Progressive Supranuclear Palsy (PSP) in comparison with Parkinson's disease (PD) and explores their possible impact on disease's features. Sixty PSP and 33 PD patients were included. Motor symptoms, cardiovascular risk factors and the age-related white matter changes (ARWMC) score was computed to rate WMH for both groups. Pearson's correlation and linear or logistic regression analysis were used to check for relationships between ARWMC and PSP clinical scores. The mean (standard deviation) ARWMC total score in the PSP cohort was 4.66 (3.25). Any degree of WMH was present in 68% of PSP (ARWMC +). Compared to ARWMC-, ARWMC + did not have greater disease severity or more cardiovascular risk factors. WMH were frequently localized in fronto-parietal lobes and were mild in severity. Linear regression analysis showed that ARWMC total score was related to the PSP-rating scale, irrespective of age, disease duration and the Charlson modified comorbidity index. Logistic regression analysis confirmed that ARWMC total score was related to the use of wheelchair, irrespective of above-mentioned covariates. Vascular risk factors as well as severity and distribution of WMH did not have an impact on the PSP phenotype. No differences were found with PD patients. Our results suggest that WMH in PSP might be markers of neurodegenerative-related pathology rather than being simple expression of atherosclerotic cerebrovascular changes.

摘要

脑白质高信号(WMH)被认为是脑小血管病的磁共振脑成像(MRI)生物标志物,但其在神经退行性相关疾病中的临床作用尚不清楚。本研究描述了进行性核上性麻痹(PSP)患者脑MRI上WMH的分布情况,并与帕金森病(PD)进行比较,探讨其对疾病特征的可能影响。研究纳入了60例PSP患者和33例PD患者。计算两组患者的运动症状、心血管危险因素以及年龄相关白质变化(ARWMC)评分以评估WMH。采用Pearson相关性分析以及线性或逻辑回归分析来检验ARWMC与PSP临床评分之间的关系。PSP队列中ARWMC总分的平均值(标准差)为4.66(3.25)。68%的PSP患者存在任何程度的WMH(ARWMC阳性)。与ARWMC阴性患者相比,ARWMC阳性患者的疾病严重程度并不更高,心血管危险因素也没有更多。WMH常位于额顶叶,且严重程度较轻。线性回归分析表明,ARWMC总分与PSP评定量表相关,不受年龄、病程和Charlson修正合并症指数的影响。逻辑回归分析证实,ARWMC总分与轮椅使用情况相关,不受上述协变量的影响。血管危险因素以及WMH的严重程度和分布对PSP表型没有影响。与PD患者相比未发现差异。我们的结果表明,PSP中的WMH可能是神经退行性相关病理的标志物,而非动脉粥样硬化性脑血管变化的简单表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11447107/22cdabd374e2/415_2024_12662_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11447107/ff5b4ff331ca/415_2024_12662_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11447107/627eb88c2238/415_2024_12662_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11447107/22cdabd374e2/415_2024_12662_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11447107/ff5b4ff331ca/415_2024_12662_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11447107/627eb88c2238/415_2024_12662_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11447107/22cdabd374e2/415_2024_12662_Fig3_HTML.jpg

相似文献

1
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy.进行性核上性麻痹中白质变化对临床表型的影响。
J Neurol. 2024 Oct;271(10):6866-6875. doi: 10.1007/s00415-024-12662-0. Epub 2024 Sep 2.
2
Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.轨迹密度成像:评估以帕金森病为主的进行性核上性麻痹白质变化的可靠方法。
Parkinsonism Relat Disord. 2019 Dec;69:23-29. doi: 10.1016/j.parkreldis.2019.10.020. Epub 2019 Oct 22.
3
Improved Automatic Morphology-Based Classification of Parkinson's Disease and Progressive Supranuclear Palsy.基于形态学的帕金森病和进行性核上性麻痹自动分类的改进。
Clin Neuroradiol. 2019 Dec;29(4):605-614. doi: 10.1007/s00062-018-0727-8. Epub 2018 Sep 14.
4
[The influence of vascular risk factors and white matter hyperintensities on the degree of motor impairment in Parkinson's disease].[血管危险因素和脑白质高信号对帕金森病运动障碍程度的影响]
Neurol Neurochir Pol. 2006 Jul-Aug;40(4):276-83.
5
Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease.进行性核上性麻痹和帕金森病中不同的脑活动模式。
Mov Disord. 2015 Aug;30(9):1248-58. doi: 10.1002/mds.26294. Epub 2015 Jul 6.
6
Track density imaging in progressive supranuclear palsy: A pilot study.进行性核上性麻痹的轨迹密度成像:一项初步研究。
Hum Brain Mapp. 2019 Apr 15;40(6):1729-1737. doi: 10.1002/hbm.24484. Epub 2018 Nov 26.
7
Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.齿状核红核束分析在进行性核上性麻痹中的诊断潜力。
Parkinsonism Relat Disord. 2018 Apr;49:81-87. doi: 10.1016/j.parkreldis.2018.02.004. Epub 2018 Feb 7.
8
DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation.多系统萎缩、帕金森病和进行性核上性麻痹额顶叶白质的 DNA 甲基化模式:交叉比较研究。
Acta Neuropathol. 2024 Jul 12;148(1):4. doi: 10.1007/s00401-024-02764-4.
9
Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy.进行性核上性麻痹中额-深部灰质通路的结构连接中断。
Neuroimage Clin. 2019;23:101899. doi: 10.1016/j.nicl.2019.101899. Epub 2019 Jun 15.
10
Whole-Brain Magnetic Resonance Spectroscopy Reveals Distinct Alterations in Neurometabolic Profile in Progressive Supranuclear Palsy.全脑磁共振波谱分析显示进行性核上性麻痹的神经代谢特征发生明显改变。
Mov Disord. 2023 Aug;38(8):1503-1514. doi: 10.1002/mds.29456. Epub 2023 Jun 8.

引用本文的文献

1
Comorbid pathologies and their impact on progressive supranuclear palsy: current view.共病病理及其对进行性核上性麻痹的影响:当前观点
J Neural Transm (Vienna). 2025 Aug 12. doi: 10.1007/s00702-025-03005-y.

本文引用的文献

1
The comorbidity and co-medication profile of patients with progressive supranuclear palsy.进行性核上性麻痹患者的合并症和合并用药情况。
J Neurol. 2024 Feb;271(2):782-793. doi: 10.1007/s00415-023-12006-4. Epub 2023 Oct 6.
2
Cerebral Small Vessel Disease and Alzheimer's Disease: A Review.脑小血管病与阿尔茨海默病:综述
Front Neurol. 2020 Aug 25;11:927. doi: 10.3389/fneur.2020.00927. eCollection 2020.
3
Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017.
2010年至2017年德国进行性核上性麻痹患者的住院率及合并症
J Clin Med. 2020 Jul 31;9(8):2454. doi: 10.3390/jcm9082454.
4
Copathology in Progressive Supranuclear Palsy: Does It Matter?进行性核上性麻痹中的共病:这有关系吗?
Mov Disord. 2020 Jun;35(6):984-993. doi: 10.1002/mds.28011. Epub 2020 Mar 3.
5
Midbrain MRI assessments in progressive supranuclear palsy subtypes.中脑 MRI 评估在进行性核上性麻痹各亚型中的应用。
J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):98-103. doi: 10.1136/jnnp-2019-321354. Epub 2019 Sep 16.
6
Hypertension and progressive supranuclear palsy.高血压与进行性核上性麻痹。
Parkinsonism Relat Disord. 2019 Sep;66:166-170. doi: 10.1016/j.parkreldis.2019.07.036. Epub 2019 Aug 3.
7
The effect of small vessel disease on motor and cognitive function in Parkinson's disease.小血管疾病对帕金森病运动和认知功能的影响。
Clin Neurol Neurosurg. 2019 Jul;182:58-62. doi: 10.1016/j.clineuro.2019.04.029. Epub 2019 May 1.
8
Motor, cognitive and behavioral differences in MDS PSP phenotypes.MDS PSP 表型在运动、认知和行为方面的差异。
J Neurol. 2019 Jul;266(7):1727-1735. doi: 10.1007/s00415-019-09324-x. Epub 2019 Apr 15.
9
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.如何应用运动障碍学会的标准来诊断进行性核上性麻痹。
Mov Disord. 2019 Aug;34(8):1228-1232. doi: 10.1002/mds.27666. Epub 2019 Mar 18.
10
Cerebral small vessel disease: neuroimaging markers and clinical implication.脑小血管病:神经影像学标志物及其临床意义。
J Neurol. 2019 Oct;266(10):2347-2362. doi: 10.1007/s00415-018-9077-3. Epub 2018 Oct 5.